Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Capital Expenditures (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Capital Expenditures for 3 consecutive years, with $9.8 million as the latest value for Q1 2026.

  • Quarterly Capital Expenditures rose 205.75% to $9.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $24.9 million through Jan 2026, up 293.16% year-over-year, with the annual reading at $1.9 million for FY2025, 84.66% down from the prior year.
  • Capital Expenditures for Q1 2026 was $9.8 million at Kestra Medical Technologies, up from $7.3 million in the prior quarter.
  • The five-year high for Capital Expenditures was $9.8 million in Q1 2026, with the low at -$9.3 million in Q1 2025.
  • Average Capital Expenditures over 3 years is $3.9 million, with a median of $5.7 million recorded in 2024.
  • The sharpest move saw Capital Expenditures crashed 108.4% in 2025, then surged 205.75% in 2026.
  • Over 3 years, Capital Expenditures stood at $4.4 million in 2024, then soared by 63.37% to $7.3 million in 2025, then skyrocketed by 34.85% to $9.8 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $9.8 million, $7.3 million, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.